MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, SLNO made $190,405K in revenue. $20,944K in net income. Net profit margin of 11.00%.

Income Overview

Revenue
$190,405K
Net Income
$20,944K
Net Profit Margin
11.00%
EPS
$0.39
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Product revenue, net
190,405
Cost of goods sold
2,700
Research and development
40,627
Selling, general and administrative
132,128
Change in fair value of contingent consideration
5,536
Total operating expenses
180,991
Operating income (loss)
9,414
Interest income, net
16,952
Interest expense
5,476
Total other income (expense), net
11,476
Net loss
20,890
Net unrealized gain on marketable securities
37
Foreign currency translation adjustment
17
Total comprehensive income (loss)
20,944
Basic EPS
0.4
Diluted EPS
0.39
Basic Average Shares
50,817,586
Diluted Average Shares
52,384,886
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income, net$16,952K Product revenue, net$190,405K Total other income(expense), net$11,476K Operating income (loss)$9,414K Interest expense$5,476K Total operatingexpenses$180,991K Net loss$20,890K Net unrealized gainon marketable...$37K Foreign currencytranslation adjustment$17K Selling, general andadministrative$132,128K Research and development$40,627K Change in fair value ofcontingent consideration$5,536K Cost of goods sold$2,700K Total comprehensiveincome (loss)$20,944K

SOLENO THERAPEUTICS INC (SLNO)

SOLENO THERAPEUTICS INC (SLNO)